Everly Health vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Everly Health logo

Everly Health

ChallengerHealthcare

At-Home Diagnostics & Virtual Care Platform

Everly Health is a diagnostics-driven virtual healthcare company offering 35+ at-home lab test kits (Everlywell) and a telehealth platform connecting results to clinical care; raised $400M+; serves employers, health plans, and consumers;

About

Everly Health is an Austin, Texas-based health technology company founded in 2015 by Julia Cheek, operating at the intersection of consumer diagnostics and virtual healthcare through two integrated platforms: Everlywell, its direct-to-consumer at-home lab testing brand, and Everly Health Solutions, its B2B enterprise telehealth and diagnostics business. The company offers over 35 at-home test kits spanning metabolic health, thyroid function, food sensitivity, STI screening, fertility hormones, vitamins, and COVID-19 — enabling consumers to collect biospecimens at home and receive clinician-reviewed results through a CLIA-certified lab network with optional telehealth follow-up care. Everlywell tests are available direct-to-consumer online and through major retailers including Target and CVS.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

Key Details

Category
At-Home Diagnostics & Virtual Care Platform
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.